Trump Cuts Health Science Funding: Decade Low
- government spending on health research have sent shockwaves through universities and related industries.
- According to Treasury Department data analyzed by Jefferies, the NIH's cash outflow dropped to $2.8 billion in May, a 28% decrease from April and the lowest as September...
- The cuts extend beyond projects related to diversity,equity,and inclusion,which the Trump administration has openly criticized.For decades, the U.S. government has relied on universities for their scientific expertise, channeling...
The Trump administration’s drastic cuts to health research funding, a primary_keyword, have plunged the National Institutes of Health (NIH) disbursements to their lowest point in a decade, creating a university budget crisis. Universities across the nation, including northwestern, face immense financial strain, leading to potential layoffs and limitations on graduate student intake. Sixteen states have already filed lawsuits challenging the funding freezes. Moreover, lab suppliers are bracing for decreased demand. Thermo Fisher and other companies anticipate muted sales due to these spending reductions,while companies like Illumina are actively working with policymakers. Stay informed with News Directory 3. Discover what’s next as legal battles and policy changes unfold.
Trump Administration Cuts Health Research Funding, Sparks university Budget crisis
Updated june 16, 2025
The Trump administration’s recent cuts to U.S. government spending on health research have sent shockwaves through universities and related industries. The National Institutes of Health (NIH), a primary source of medical research grants, has seen its disbursements plummet, forcing academic institutions to tap into their endowments and impacting companies that supply laboratories.
According to Treasury Department data analyzed by Jefferies, the NIH’s cash outflow dropped to $2.8 billion in May, a 28% decrease from April and the lowest as September 2014. This NIH funding reduction has already led to the elimination of grants for pancreatic cancer research at the University of florida and a coronavirus study at Washington State University, according to Grant Watch, a website tracking these cuts.
The cuts extend beyond projects related to diversity,equity,and inclusion,which the Trump administration has openly criticized.For decades, the U.S. government has relied on universities for their scientific expertise, channeling billions of dollars through the NIH. In 2024, the NIH’s budget totaled $47.7 billion, with approximately 80% allocated to universities and hospitals for specific research projects, according to the Congressional Research Service.
President Trump’s administration is withholding federal funds from institutions like Harvard and Columbia, citing alleged left-wing bias and tolerance of antisemitism. The NIH funding freeze has created significant budget challenges for universities nationwide. Northwestern University, as a notable example, is reportedly spending about $40 million monthly to cover the shortfall, according to Carole LaBonne, a professor at the university.
LaBonne said research labs face difficult decisions about potential layoffs and limiting graduate student intake. A Northwestern University spokesman confirmed the university has not received official notification of a funding freeze but continues to spend millions to sustain research efforts.
Sixteen states have filed lawsuits against the NIH, alleging unlawful withholding or unreasonable delays in funding. A hearing is scheduled for Monday in Boston.
The funding freezes have also forced universities to cancel purchase orders, impacting companies that supply lab equipment and materials. Thermo Fisher Scientific CEO Marc Casper noted in April that academic demand would likely remain soft for the remainder of the year. A company spokeswoman added that U.S. academic and government business accounts for about 7% of thermo Fisher’s revenue, and they anticipate slightly muted sales.
Other companies affected by the budget cuts include 10x Genomics, Standard BioTools, and Pacific Biosciences, according to Jefferies. illumina CEO Jacob Thaysen acknowledged the ”headwinds” caused by the U.S.budget cuts in May but expressed optimism that the situation is temporary.An Illumina spokeswoman said they are actively working with policymakers to advocate for the preservation of critical research funding.
During a recent senate hearing, NIH Director Jay Bhattacharya faced bipartisan scrutiny regarding the grant terminations. Bhattacharya said there is an appeals process for halted grants and expressed hope that universities “will come to terms so that we can move forward.”
What’s next
The legal challenges and ongoing negotiations between universities, the NIH, and policymakers will likely determine the future of research funding and its impact on academic institutions and related industries.